Another recent publication reported that patients with metabolic diseases (obesity, type 2 diabetes, metabolic syndrome, cardiovascular disease, and nonalcoholic fatty liver disease) had a significant decrease in TNF-α plasma levels with CoQ10 supplementation but not CRP or IL-6 [31]. Here, CRP is linked to obesity disorder.